Literature DB >> 12931287

Argon plasma coagulation (APC) surgery in otorhinolaryngology.

Wolfgang F Bergler1.   

Abstract

The Argon Plasma Coagulation (APC) technique has been used with success in open surgery and endoscopy for hemostasis and thermal devitalisation of pathological tissue. We developed techniques and instruments for the use of this technique in Otorhinolaryngology, because of its excellent hemostatic effects and devitalising properties. APC surgery is based on a monopolar high-frequency (HF) electrical current transmitted through ionized argon gas from the tip of an applicator to the tissue surface in a contact-free mode. Indications for the use of this technique include hyperplasia of the inferior turbinate in nasal obstruction, recurrent epistaxis in hereditary hemorrhagic telangiectasia, leukoplakia of the mucosa, recurrent respiratory papillomatosis (RRP) of the lower airway, in combination with flexible systems. A combined technique of blunt dissection and plasma coagulation has been designed for bloodless removal of the tonsils. This new technique offers a wide variety of advantages. The limited penetration depth makes APC surgery a safe procedure; damage to neighbouring tissue can be avoided. The APC technique is a useful and comparable inexpensive method to achieve devitalisation of tissues and easy to handle hemostasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931287

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  3 in total

Review 1.  [Prevention and therapy of hemorrhage in the HNO region. Specialist and interdisciplinary aspects].

Authors:  K-W Delank
Journal:  HNO       Date:  2005-02       Impact factor: 1.284

2.  Surgery of the turbinates and "empty nose" syndrome.

Authors:  Marc Oliver Scheithauer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27

3.  Safety and bactericidal efficacy of cold atmospheric plasma generated by a flexible surface Dielectric Barrier Discharge device against Pseudomonas aeruginosa in vitro and in vivo.

Authors:  Gabrielle S Dijksteel; Magda M W Ulrich; Marcel Vlig; Ana Sobota; Esther Middelkoop; Bouke K H L Boekema
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-08-19       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.